Form IRANNOTICE - Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)).
24 2월 2024 - 4:02AM
Edgar (US Regulatory)
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Securities and Exchange
Commission 100 F Street, N.E. |
|
|
|
|
|
|
Washington, DC 20549 |
February 23, 2024
Re: Notice of disclosure filed in Exchange Act Annual Report under Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012
and Section 13(r) of the Exchange Act
Dear Sirs:
Pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the Securities Exchange Act
of 1934, as amended, notice is hereby provided that Sanofi has made disclosure pursuant to those provisions in its Annual Report on Form 20-F for the year ended December 31, 2023, which was filed
with the Securities and Exchange Commission on February 23, 2024.
Sincerely,
|
|
| /s/ Alexandra Roger |
| Alexandra Roger
Head of Legal Corporate and Finance |
Sanofi (NASDAQ:SNY)
과거 데이터 주식 차트
부터 1월(1) 2025 으로 2월(2) 2025
Sanofi (NASDAQ:SNY)
과거 데이터 주식 차트
부터 2월(2) 2024 으로 2월(2) 2025
